MSK Partners With OpenEvidence, Binging OncoKB Precision Oncology Data to Doctors
benxneo · x · 2026-09-17
- Memorial Sloan Kettering Cancer Center (MSK) and OpenEvidence announced a partnership to advance precision oncology.
- The deal includes integrating OpenEvidence into MSK's Epic workflow and bringing OncoKB™, MSK's precision oncology knowledge base, into OpenEvidence for physicians outside MSK.
- OncoKB remains the only somatic cancer variant knowledge base partially recognized by the FDA, pairing curated biomarker evidence with patient context for point-of-care decision support.
More from Companies & People
- Doctors wait up to a year to start: PE-backed staffing firm's Excel-bound credentialing process laid bare — alex_verem · 2026-11-02
- Claude upgrade-page traffic rebounded to 17.6M in September, near May's 18.6M peak — firstadopter · 2026-11-02
- Google launches Skilling Africa to train 3M Africans in AI and digital skills by 2030 — weskambale · 2026-11-02
- Non-technical execs drive AI coding course boom around Doubao, prizing output over SOTA — huangyun_122 · 2026-11-02
- Alibaba Qwen exec sells AI token credits in Li Jiaqi's livestream targeting women — yangyi · 2026-11-02
- Essay argues you can't understand Anthropic without imagining Los Alamos physicists after Trinity — himanshustwts · 2026-11-02